Edition:
United States

Navidea Biopharmaceuticals Inc (NAVB.A)

NAVB.A on American Stock Exchange

0.45USD
22 May 2017
Change (% chg)

$-0.01 (-1.30%)
Prev Close
$0.46
Open
$0.45
Day's High
$0.46
Day's Low
$0.45
Volume
17,754
Avg. Vol
85,589
52-wk High
$1.14
52-wk Low
$0.26

Select another date:

Tue, May 9 2017

BRIEF-Navidea Biopharmaceuticals reports Q1 earnings $0.53/shr

* Navidea Biopharmaceuticals reports first quarter 2017 financial results

BRIEF-Navidea Q4 loss per share $0.02

* Navidea provides corporate update and reports full year 2016 results

BRIEF-Navidea Biopharmaceuticals files for non timely 10-K

* Navidea biopharmaceuticals files for non timely 10-k - sec filing

BRIEF-Cardinal Health reports 5.8 pct passive stake in Navidea Biopharma

* Cardinal Health, Inc reports 5.8 percent passive stake in navidea biopharmaceuticals inc as of March 3, 2017 - sec filing Source text for Eikon: Further company coverage:

BRIEF-Court entered interlocutory order declaring Navidea, Macrophage committed one or more events of default under loan agreement

* On Feb 9, court entered interlocutory order declaring Navidea, Macrophage committed one or more events of default under loan agreement

BRIEF-Navidea Biopharmaceuticals enters asset purchase agreement with Cardinal Health

* Press release - Navidea signs asset purchase agreement with Cardinal Health

Select another date:

More From Around the Web